ArticleTransplantation and cellular therapy2025

Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients.

Gyuri Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.